// STATE LEGISLATION TRACKER

Missouri HB 2744: Requires instruction on human growth and development in schools

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: In committee

State: Missouri
Bill: HB 2744
Session: 2026
Filed: 2026-01-06
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Missouri HB2744 appears to be an education bill requiring human growth and development instruction in schools. Based on the title, subjects, and latest action, it does not appear to regulate peptides, prescribing, telehealth, clinician scope, compounding, controlled substances, or prescription monitoring.

Key Points

No apparent impact on compounded peptide access
No apparent change to off-label prescribing rules
No apparent change to telehealth peptide care
No apparent change to NP or naturopathic scope
No apparent change to 503A or 503B compounding

What to Watch For

Note Watch only for amendments that add health care, prescribing, pharmacy, or drug-related language.

Note The current subject area is school instruction, not medical practice or peptide access.

Where the Bill Stands

The bill was referred to the House Emerging Issues Committee and has not passed a chamber.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws